Plans to invest ‘mid-double-digit million Euro’ over next three years at the plant
Dr Frank Heinricht, Chairman of Schott, inaugurates the new Machine Overhauling Centre at Lukacshaza with Hans-Joachim Konz, Board Member of Schott, Andreas Reisse, Vice President Pharmaceutical Packaging, Christoph Doeppes, Managing Director of the Schott site in Lukacshaza, as well as Ferenc Kovacs, Chairman of the Hungarian conference of county delegates, Janos Virag, Mayor of Lukacshaza, and the entire project team
Schott Pharmaceutical Systems is to expand its Hungarian site in Lukácsháza, which manufactures pharmaceutical primary packaging
The German manufacturer of glass packaging plans to invest ‘in the mid-double-digit million euro range’ at the plant from now until 2016.
The first step will be to open a new maintenance facility for overhauling and upgrading production machines that will create more than 30 new jobs in the Lukácsháza region. In addition, production capacity should continue to increase in Hungary over the next few years.
‘Our commitment here is long-term in nature and we are working together with the local authorities on further developing this site,’ said Christoph Döppes, Managing Director at Lukácsháza.
Besides opening its new machine building facility and expanding its production capacities at Lukácsháza, Schott also plans to create a number of new skilled jobs for machine builders, technicians and engineers.
Our commitment here is long-term in nature and we are working together with the local authorities on further developing this site
Schott manufactures ampoules, vials, and cartridges for the pharmaceutical industry at the plant, which was opened in 1993. Today, the plant employs around 530 people and has an annual production of more than 1.7 billion units. It is Schott Pharmaceutical Division’s single largest site, with products mainly exported across Europe and overseas, but they are also produced for the local market.
Frank Heinricht, Schott’s Chairman, said the expansion of the site in Hungary is only part of the firm’s global investment strategy. Going forward, Schott also intends to install new production lines at the plant.
‘On average, our annual production of ampoules, cartridges and vials will increase by almost half at this site,’ said Heinricht. ‘With our investment strategy, we will be helping our customers around the world to meet their quality and growth targets.’
Schott also recently opened a new plant in India and significantly expanded its capacities in Indonesia and Russia. A new joint venture in China also expands its global manufacturing network further.